KRISTINA HEDIN-GOLDSMITH: Open Payments
NPI 1235279944 · MURRAY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 22 payments from 7 companies in 2025. Trend: 2023 $231 · 2024 $228 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 10 | $180 |
| Astellas Pharma US Inc | 3 | $56 |
| Biogen, Inc. | 2 | $47 |
| SHIELD THERAPEUTICS INC | 2 | $40 |
| Organon LLC | 2 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $4 |
Products named: SLYND, TWIRLA, Veozah, ZURZUVAE, ACCRUFER, NEXPLANON, MYFEMBREE.
Industry payments across UT — which companies pay providers there.
